Overview

A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer

Status:
Completed

Trial end date:
2013-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the feasibility of chemotherapy, consisting of docetaxel, cisplatin and capecitabine given prior to surgery for stomach cancer. Furthermore, an extended type of removal of lymph nodes will be implemented.

Phase:

Phase 2

Details

Lead Sponsor:

Jeroen Bosch Ziekenhuis

Collaborator:

Eindhoven Cancer Registry

Treatments:

Capecitabine
Cisplatin
Docetaxel